- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imatron 1994 revenues rise by 34%
Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31). Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits
Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31).
Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits were $2.3 million.
The financial good news is a continuation of positive trendsthat emerged in the second half of 1993, according to S. LewisMeyer, chief executive officer.
"The company moves into 1995 with a strong backlog anda high degree of optimism in our ability to continue growing,"he said.
Imatron is gearing up sales and marketing efforts in the PacificRim, Latin America and the Middle East. The launch of HeartScan,a subsidiary that will manage artery disease risk assessment centersequipped with Imatron high-speed CT scanners, is scheduled forthe first quarter of 1995, Meyer said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
